Dingkang (Wuhan) Biopharmaceutical Co., Ltd.

Dingkang Biologics is a leading CDMO company, offering one-stop CMC solutions that support from early drug development to late-stage clinical research and commercial cGMP manufacturing. Dingkang has introduced Kubio, the world's first modular biopharmaceutical plant; multiple products developed for clients are already undergoing clinical trials in more than 20 countries worldwide. In the near future, Dingkang Biologics' total production capacity will exceed 140,000 liters. We are committed to making biologics of international standards affordable to patients globally through technological and production innovation, improving therapeutic levels to enhance human health. Notice: Dear job seekers, Recently, our company has discovered that some unscrupulous individuals have been impersonating our staff to conduct recruitment activities and defraud money. The specific methods are as follows: 1. Contact job seekers under the pretext of recruitment; 2. Propose that candidates must participate in a "data analysis assessment" before onboarding, thereby inducing victims to download illegal mobile apps; 3. Use promises of high returns as bait to trick victims into recharging funds within the app; 4. Under the pretext of "data corruption," require victims to recharge again for data recovery. We have reported the above behaviors to the police and reserve the right to further pursue the legal liability of the wrongdoers. Now, we hereby solemnly declare that we conduct recruitment activities through legitimate recruitment platforms such as "Zhaopin"; our official email addresses use the domain suffix @*. We do not charge any fees in recruitment and will not require job seekers to make transfers. Please carefully identify the above information and avoid being scammed. If you discover any illegal or criminal activities or suffer losses, please immediately protect your rights through legal means such as reporting to public security authorities.